Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allogeneic adoptive immunotherapy].

P Tiberghien1, E Robinet, C Ferrand

  • 1Inserm EPI 0119/Upres EA 2284, Etablissement français du Sang Bourgogne-Franche-Comté, université de Franche-Comté, 1, boulevard Alexandre-Fleming, BP 1937, 25020 cedex, Besançon, France. pierre.tiberghien@efs.sante.fr <pierre.tiberghien@efs.sante.fr>

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|June 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opinion paper: A regional feed action plan - one-of-a-kind example from East Africa.

Animal : an international journal of animal bioscience·2020
Same author

Change of depressive symptoms in a French nine-year longitudinal study of aging: Gender differences and relationships between social support, health status and depressive symptoms.

Archives of gerontology and geriatrics·2020
Same author

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.

Oncoimmunology·2018
Same author

Dietary patterns in french home-living older adults: Results from the PRAUSE study.

Archives of gerontology and geriatrics·2017
Same author

Dietary patterns in French home-living older adults: Results from the PRAUSE study.

Archives of gerontology and geriatrics·2017
Same author

The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.

Oncogene·2016
Same journal

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

Allogeneic hematopoietic transplantation, utilizing immune cells from a donor graft, is a powerful immunotherapy. However, this life-saving treatment is limited by significant toxicity.

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Science

Context:

  • Allogeneic hematopoietic transplantation is a critical medical procedure.
  • Immune cells within the hematopoietic graft play a crucial role.
  • The perception of this transplant modality has evolved significantly.

Purpose:

  • To highlight the dual nature of allogeneic hematopoietic transplantation.
  • To underscore the importance of immune cells in graft efficacy.
  • To acknowledge the associated toxicities of this immunotherapy.

Summary:

  • The recognition of immune cells in hematopoietic grafts has reshaped the understanding of allogeneic hematopoietic transplantation.
  • This procedure is now viewed as a potent form of adoptive allogeneic immunotherapy.

Related Experiment Videos

  • Despite its efficacy, significant toxicity remains a major challenge.

    • Impact:

    • This evolving perception influences clinical strategies and research directions in transplantation.
    • Understanding the role of graft immune cells is key to mitigating transplant-related toxicities.
    • Further research is needed to optimize the balance between therapeutic benefits and toxicity in allogeneic hematopoietic transplantation.